A choppy history of racial bias in oximetry

Covid-19 has put oximeters and their inability to accurately assess blood oxygen levels in people of colour back in the spotlight.

IN DEPTH

Women’s health clinical trials: breaking down barriers through decentralisation

Comment

Over-the-counter hearing aids market not yet ready to flourish

Go to article: Home | A choppy history of racial bias in oximetryGo to article: In this issueGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: BriefingGo to article: Industry newsGo to article: The medical industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Repsol Company Insight Go to article: Repsol Go to article: LaservormGo to article: CommentGo to article: Over-the-counter hearing aids market not yet ready to flourishGo to article: Reprocessing of single-use devices lowers costs in cardiac operating suitesGo to article: 35,000 enrolled in the most diverse colorectal cancer screening test clinical trialGo to article: MelexisGo to article: SartoriusGo to article: facultyGo to article: In DepthGo to article: A choppy history of racial bias in oximetryGo to article: Women’s health clinical trials: breaking down barriers through decentralisationGo to article: Continuous manufacturing builds on hype but adoption remains gradualGo to article: AI in clinical trial adherence and retention: is it a Pandora’s box?Go to article: Sandvik Company InsightGo to article: Sandvik Go to article: In DataGo to article: The medical industry found it harder to fill cloud vacancies in Q1 2022Go to article: Partnerships decreased significantly in the medical industry in H2 2021Go to article: EventsGo to article: Next Issue